Specify a stock or a cryptocurrency in the search bar to get a summary
OS Therapies Incorporated
OSTXOS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland. Address: 15825 Shady Grove Road, Rockville, MD, United States, 20850
Analytics
WallStreet Target Price
15 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures OSTX
Dividend Analytics OSTX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OSTX
Stock Valuation OSTX
Financials OSTX
Results | 2019 | Dynamics |